You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Vimentin antibody [V9] (ab8069)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Vimentin antibody [V9]
See all Vimentin products (41) ...

Description

Mouse monoclonal [V9] to Vimentin

Specificity

The antibody stains the 57 kD vimentin band in immunoblots performed on a lysate of normal human lymphocytes. Does not react with GFAP, neurofilamen or desmin.

Tested applications

ICC/IF, Flow Cyt, IHC-FoFr, IHC-P, IHC-Fr, WBmore details

Cross reactivity

Reacts with

Rat, Horse, Chicken, Cow, Cat, Dog, Human, Pig

Does not react with

Mouse

Immunogen

Porcine Lens

Positive control

This antibody gave a positive signal in HeLa and MOLT4 whole cell lysates.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: PBS, pH 7.4

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

V9

Isotype

IgG1

  • Western blot - Vimentin antibody [V9] (ab8069)Western blot - Vimentin antibody [V9] (ab8069) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Vimentin antibody [V9] (ab8069)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Vimentin antibody [V9] (ab8069) image (enlarge)

  • Flow Cytometry-Vimentin antibody [V9](ab8069)Flow Cytometry-Vimentin antibody [V9](ab8069) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab8069 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells.

Tissue specificity

Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines.

Sequence similarities

Belongs to the intermediate filament family.

Post-translational
modifications

Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments.

Target information above from: UniProt accessionP08670 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Form

Vimentin is found in connective tissue and in the cytoskeleton.

Alternative names

  • FLJ36605 antibody
  • OTTHUMP00000019224 antibody
  • VIM antibody
  • VIME_HUMAN antibody
  • Vimentin antibody
see all

Anti-Vimentin antibody [V9] images:

  Western blot - Vimentin antibody [V9] (ab8069)

Western blot - Vimentin antibody [V9] (ab8069)

All lanes : Anti-Vimentin antibody [V9] (ab8069) at 1 µg/ml

Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 2 : MOLT4 (Human acute lymphoblastic leukemia cell line) Whole Cell Lysate

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed (ab97040) at 1/5000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 54 kDa
Observed band size : 57 kDa (why is the actual band size different from the predicted?)


Exposure time : 20 minutes

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Vimentin antibody [V9] (ab8069)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Vimentin antibody [V9] (ab8069)

IHC image of Vimentin staining in human Hodgkin's Lymphoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab8069, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX

  Flow Cytometry-Vimentin antibody [V9](ab8069)

Flow Cytometry-Vimentin antibody [V9](ab8069)

Overlay histogram showing HeLa cells stained with ab8069 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100® for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab8069, 1/20 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Triton X-100® used under the same conditions.

  Immunocytochemistry/ Immunofluorescence - Vimentin antibody [V9] (ab8069)

Immunocytochemistry/ Immunofluorescence - Vimentin antibody [V9] (ab8069)

ab8069 staining Vimentin in human epithelial ovarian serous adenocarcinoma cell line SKOV-3 by Immunocytochemistry/ Immunofluorescence.

Samples were fixed with 4% PFA in PBS pH 7.4 and then permeabilised using 0.2% saponin for 30 minutes. A blocking step was performed using 1% BSA/PBS for 1 hour. Samples were then incubated with ab8069 at a 1/200 dilution in 1% BSA/PBS for 1 hour. The secondary antibody was a goat anti-mouse Alexa 488 (green) diluted 1/1000, 1% BSA/PBS for 1 hour. Samples were then incubated with phalloidin (red for actin staining) in 1% BSA/PBS for 45 minutes and counterstained with DAPI (blue for nuclei staining) in PBS for 45 minutes.

Image from Loessner D et al, Biomaterials. 2010 Nov;31(32):8494-506. Epub 2010 Aug 14. doi:10.1016/j.biomaterials.2010.07.064

  Immunocytochemistry/ Immunofluorescence-Vimentin antibody [V9](ab8069)

Immunocytochemistry/ Immunofluorescence-Vimentin antibody [V9](ab8069)

ICC/IF image of ab8069 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab8069, 1µg/ml) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1h.Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-Vimentin antibody [V9] (ab8069)

This product has been referenced in:

  • Mark Kristiansen et al Disease Related prion protein form aggreasomes in Neuronal Cells leading to Caspase Activiation and Apoptosis. The Journal of Biological Chemistry 280:38851-38861 (2005).Read more (PubMed: ) »
  • Rausch Vet al. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res 70:5004-13 (2010). IHC-Fr; Human.Read more (PubMed: 20530687) »

See all 6 publications for this product

Publishing research using ab8069? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"